Form 4: Ameresco EVP Corrsin Reports Equity Transactions
Insider Transaction Report
Ameresco's EVP and General Counsel, David J. Corrsin, reported new equity awards and a tax-related stock sale, along with a correction to a previous filing.
Summary
- A clerical error in a previous Form 4 filing for March 8, 2026 RSU vesting was corrected, changing the reported number of shares sold from 50 to 19.
- David J. Corrsin directly acquired 20,000 stock options and 3,500 Restricted Stock Units (RSUs) on March 10, 2026.
- Corrsin's spouse indirectly acquired 4,000 stock options and 350 RSUs on March 10, 2026.
- 50 shares of Class A Common Stock were indirectly acquired by Corrsin's spouse on March 10, 2026, likely from RSU conversion.
- 19 shares of Class A Common Stock were indirectly disposed of by Corrsin's spouse on March 12, 2026, at a price of $25.31 per share, to cover withholding taxes related to RSU vesting.
- 50 Restricted Stock Units were indirectly disposed of by Corrsin's spouse on March 10, 2026, likely due to conversion or vesting.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, reflecting routine executive compensation and tax-related transactions. The new equity grants indicate continued alignment of executive interests with shareholder value, while the tax-related sale is a standard occurrence.
Positives
- Grant of 20,000 stock options directly to David J. Corrsin, aligning executive interests with long-term company performance.
- Grant of 3,500 Restricted Stock Units (RSUs) directly to David J. Corrsin, providing future equity incentives.
- Grant of 4,000 stock options indirectly to David J. Corrsin's spouse.
- Grant of 350 Restricted Stock Units (RSUs) indirectly to David J. Corrsin's spouse.
Negatives
- Sale of 19 Class A Common Stock shares at $25.31 to cover applicable withholding taxes, which is a routine but non-discretionary disposition.
Future Outlook
Stock options granted on March 10, 2026, will vest 20% on each anniversary of the grant date over a period of five years. Restricted Stock Units granted on March 10, 2026, will vest 25% on each 6-month anniversary of the applicable grant date over two years.
Management Comments
- The reporting person disclaims beneficial ownership of the shares held by his spouse, and this report should not be deemed an admission that the reporting person is the beneficial owner of his spouse's shares for purposes of Section 16 or for any other purpose.
Industry Context
StockSavvy.ai notes that these transactions are typical for executive compensation packages, involving the grant of equity awards and subsequent sales to cover tax obligations upon vesting. Such filings are routine disclosures for publicly traded companies.
Related Party Transactions
- Transactions involving the reporting person's spouse, with a disclaimer of beneficial ownership by the reporting person for Section 16 purposes.
Stakeholder Impact
- Shareholders: The grant of equity awards to an executive aligns management's interests with long-term shareholder value. The small tax-related sale is a routine event and is unlikely to have a significant impact.
Next Steps
- Vesting of 20,000 stock options (direct) at 20% annually over five years from March 10, 2026.
- Vesting of 3,500 Restricted Stock Units (direct) at 25% each 6-month anniversary over two years from March 10, 2026.
- Vesting of 4,000 stock options (indirect by spouse) at 20% annually over five years from March 10, 2026.
- Vesting of 350 Restricted Stock Units (indirect by spouse) at 25% each 6-month anniversary over two years from March 10, 2026.
Key Dates
| Date | Description |
|---|---|
| 03/08/2023 | Date automatic sell-to-cover instruction was signed. |
| 03/08/2026 | Date of RSU vesting mentioned in the context of a clerical error correction. |
| 03/10/2026 | Grant date for new stock options and Restricted Stock Units (RSUs), and transaction date for certain acquisitions and dispositions. |
| 03/12/2026 | Transaction date for the sale of shares and the filing date of this Form 4. |
Recommendation
holdThis Form 4 primarily details routine executive compensation grants and a standard tax-related sell-to-cover transaction. It does not provide new fundamental information about Ameresco's operational performance or strategic direction that would warrant a change in investment recommendation. The grants align executive interests with long-term shareholder value, but the small tax-related sale is a common occurrence.
Keywords
Ameresco, AMRC, Form 4, Insider Transaction, Executive Compensation, Stock Options, Restricted Stock Units, David J. Corrsin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.